PDE inhibitors and combinations thereof for the treatment of urological disorders

Details for Australian Patent Application No. 2006299232 (hide)

Owner Bayer HealthCare AG

Inventors Tinel, Hanna; Sandner, Peter; Hutter, Joachim; Ulbrich, Ernst

Agent Davies Collison Cave

Pub. Number AU-A-2006299232

PCT Pub. Number WO2007/039075

Priority 06007776.5 13.04.06 EP; 05021261.2 29.09.05 EP

Filing date 16 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 31/00 (2006.01)

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

C12Q 1/44 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving esterase

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039075 Priority application(s): WO2007/039075

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft Assignments before Grant, Section 113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299233-Niobium compound

2006299223-Process for producing a frozen aerated composition